Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 14-Jul-2020 5:20 PM EDT
Researchers study whether vadadustat, an investigational therapy, could mitigate acute lung injury in COVID-19 patients
University of Texas Health Science Center at Houston

Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at UTHealth.

Released: 14-Jul-2020 8:05 AM EDT
Keck Medicine of USC enrolling patients as part of international clinical trial to study antiviral drug as treatment for COVID-19
Keck Medicine of USC

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

10-Jul-2020 1:05 PM EDT
Severely Damaged Human Lungs Can Now Be Successfully Recovered
Columbia University School of Engineering and Applied Science

A multidisciplinary team from Columbia Engineering and Vanderbilt University has now demonstrated that severely injured donor lungs that have been declined for transplant can be recovered outside the body by a system that uses cross-circulation of whole blood between the donor lung and an animal host. For the first time, a severely injured human lung that failed to recover using the standard clinical EVLP was successfully recovered during 24 hours on the team’s cross-circulation platform.

Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:55 AM EDT
Otago researchers find link between rape and breathing problems
University of Otago

Rape and sexual trauma may have long-lasting consequences for physical health as well as mental health, University of Otago researchers have found.

   
Released: 9-Jul-2020 8:05 AM EDT
The Medical Minute: Separating mask myths from facts
Penn State Health

We see and hear new COVID-19 news almost every minute of the day. But separating facts from fiction can get challenging, especially when it comes to masks. We bust some common mask myths with two Penn State Health experts.

Released: 7-Jul-2020 10:20 AM EDT
Expanded Efforts, Focused Approach
University of Kansas Cancer Center

Physicians and scientists at The University of Kansas Cancer Center are committed to improving lung cancer outcomes in Kansas.

Released: 6-Jul-2020 11:00 AM EDT
Asthma Does Not Seem to Increase the Severity of COVID-19
Rutgers University-New Brunswick

Asthma does not appear to increase the risk for a person contracting COVID-19 or influence its severity, according to a team of Rutgers researchers.

6-Jul-2020 8:05 AM EDT
Follow-Up Appointments for Children Hospitalized for Bronchiolitis May Not Be Needed; New Study Findings Could Guide Treatment During COVID Pandemic
Intermountain Healthcare

A new study at Intermountain Primary Children’s Hospital in Salt Lake City has found that follow-up appointments for hospitalized children treated for childhood bronchitis are often not necessary, and that switching from mandatory to “as-needed” follow-up care can save families from unnecessary medical care and expense – and may help guide treatment during the COVID-19 pandemic.

Released: 6-Jul-2020 9:00 AM EDT
Study confirms ‘classic’ symptoms of COVID-19
University of Sheffield

A persistent cough and fever have been confirmed as the most prevalent symptoms associated with COVID-19 according to the new international research

Released: 2-Jul-2020 11:50 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

24-Jun-2020 11:00 AM EDT
Common Fireworks Release Toxic Metals Into the Air
NYU Langone Health

Some of America’s favorite Independence Day fireworks emit lead, copper, and other toxins, a new study suggests. These metals, which are used to give fireworks their vibrant color, also damage human cells and animal lungs.

   
Released: 1-Jul-2020 8:00 AM EDT
Understanding Molecular Mechanisms of Air Pollution’s Impact on Interstitial Lung Disease is Critical to Minimizing its Effects
American Thoracic Society (ATS)

More research must be done to investigate the role of air pollution on the epigenome in patients with interstitial lung diseases (ILDs), in order to develop strategies that minimize the effects of these pollutants, according to a new article published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Released: 30-Jun-2020 4:55 PM EDT
UTEP Research Reveals More About Path Bacterial Pathogen Travels to Cause Tuberculosis
University of Texas at El Paso

Jianjun Sun, Ph.D., associate professor in UTEP’s Department of Biological Sciences, led the research on Mycobacterium tuberculosis (Mtb). Sun’s lab has been investigating the mechanisms of Mtb pathogenesis for more than 10 years at UTEP with a specific focus on EsxA, which is a virulence factor essential for Mtb virulence and a preferred target for developing novel anti-TB drugs and vaccines.

Released: 30-Jun-2020 1:20 PM EDT
Cover your nose—Why proper mask wear and adjustment for breathing comfort is important amid COVID-19
LifeBridge Health

During the coronavirus (COVID-19) pandemic, you’ve probably noticed countless people in public spaces wearing face coverings in a way that leaves their noses uncovered.

Released: 30-Jun-2020 11:50 AM EDT
For Cardiac Rehab Patients, In-Home Portable Air Cleaners Lower Fine-Particle Pollutant Exposure
Wolters Kluwer Health: Lippincott

Using an in-home portable air cleaner (PAC) can significantly reduce exposure to fine-particle air pollutants – a major risk factor for cardiovascular events in people with pre-existing heart disease, reports a pilot study in the July issue of Journal of Cardiopulmonary Rehabilitation and Prevention. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 29-Jun-2020 12:25 PM EDT
Even in the worst COVID-19 cases, the body launches immune cells to fight back
La Jolla Institute for Immunology

SHAREInternational collaboration provides important piece of COVID-19 puzzleLA JOLLA—A new study from researchers at La Jolla Institute for Immunology (LJI) and Erasmus University Medical Center (Erasmus MC) shows that even the sickest COVID-19 patients produce T cells that help fight the virus. The study offers further evidence that a COVID-19 vaccine will need to elicit T cells to work alongside antibodies.

Released: 29-Jun-2020 10:35 AM EDT
Clues to COVID-19 Complications Come from NET-like Inflammatory Response
University of Utah Health

An overactive defense response may lead to increased blood clotting, disease severity, and death from COVID-19. A phenomenon called NETosis—in which infection-fighting cells emit a web-like substance to trap invading viruses—is part of an immune response that becomes increasingly hyperactive in people on ventilators and people who die from the disease.



close
2.63801